Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Author:
Masahisa Katsuno,Haruhiko Banno,Keisuke Suzuki,Yu Takeuchi,Motoshi Kawashima,Ichiro Yabe,Hidenao Sasaki,Masashi Aoki,Mitsuya Morita,Imaharu Nakano,Kazuaki Kanai,Shoichi Ito,Kinya Ishikawa,Hidehiro Mizusawa,Tomotaka Yamamoto,Shoji Tsuji et al.
Publication:
The Lancet Neurology
Copyright © 2010 Elsevier Ltd. All rights reserved.